Nurix Therapeutics (NRIX) Proxy filing summary

Voting matters and shareholder proposals

• Election of three Class III directors: Arthur T. Sands, Roger Dansey, and Paul M. Silva, with board recommending a vote in favor.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending November 30, 2026.

• Advisory vote to approve executive compensation for named executive officers, with board recommending approval.

• Additional business may be addressed if properly presented at the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends re-election of three Class III directors at the 2026 annual meeting.

Audit committee and external auditor matters

• Proposal to ratify PricewaterhouseCoopers LLP as the independent registered public accounting firm for the upcoming fiscal year.